Last reviewed · How we verify
amoxicillin plus clavulanic acid — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
amoxicillin plus clavulanic acid (amoxicillin plus clavulanic acid) — Consorci Sanitari de Terrassa.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| amoxicillin plus clavulanic acid TARGET | amoxicillin plus clavulanic acid | Consorci Sanitari de Terrassa | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- amoxicillin plus clavulanic acid CI watch — RSS
- amoxicillin plus clavulanic acid CI watch — Atom
- amoxicillin plus clavulanic acid CI watch — JSON
- amoxicillin plus clavulanic acid alone — RSS
Cite this brief
Drug Landscape (2026). amoxicillin plus clavulanic acid — Competitive Intelligence Brief. https://druglandscape.com/ci/amoxicillin-plus-clavulanic-acid. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab